Provenge may be given prior to docetaxel chemotherapy in patients with asymptomatic or mildly symptomatic metastatic CRPC, but for patients who had been identified as having metastases, it was unclear whether P
MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. http-equiv="content-type"